The pharmacologic spectrum of furosemide

Journal of Veterinary Emergency and Critical Care

Volumn 18, Issue 1, 2008, Pages 26-39

  Abbott, Lisa M ^a,c   Kovacic, Jan ^b  

^a Southern Oregon Veterinary Specialty Center   (United States)

^b Fox Valley Animal Referral Center   (United States)

^c NONE   (United States)

Author keywords

Antiseizure; Bronchospasm; Frusemide; Loop diuretic; Vasodilator

Indexed keywords

ANIMALIA;

EID: 38849169805     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2007.00267.x     Document Type: Review

References (132)

1. Klatt P, Muschaweck R, Bossaller W, et al. Method of collecting urine and comparative investigation of quantities excreted by cats and dogs after administration of furosemide. Am J Vet Res 1975 36 (7) : 919 923.
2. Chasse R. Diuretics, erythropoietin, and other medications used in renal failure. In : Chernow B. ed. The Pharmacologic Approach to the Critically Ill Patient. Baltimore : Williams & Wilkins 1983, pp. 632 639.
3. Brater DC. Diuretic therapy. N Engl J Med 1998 339 (6) : 387 395.
4. Péron JM, Bureau C, Gonzalez L, et al. Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to central venous pressure: a prospective pilot study. Am J Gastroenterol 2005 100 (12) : 2702 2707.
5. Adin DB, Taylor AW, Hill RC, et al. Intermittent bolus injection versus continuous infusion of furosemide in normal adult greyhound dogs. J Vet Intern Med 2003 17 (5) : 632 636.
6. Russell JM. Sodium-potassium-chloride cotransport. Physiol Rev 2000 80 (1) : 211 276.
7. Chen H, Sun D. The role of Na-K-Cl co-transporter in cerebral ischemia. Neurol Res 2005 27 (3) : 280 286.
8. Gagnon E, Bergeron MJ, Brunet GM, et al. Molecular mechanisms of Cl- transport by the renal Na(+)-K(+)-Cl(-) cotransporter. J Biol Chem 2004 279 (7) : 5648 5654.
9. Iwamoto LM, Fujiwara N, Nakamura KT, et al. Na-K-2Cl cotransporter inhibition impairs human lung cellular proliferation. Am J Physiol Lung Cell Mol Physiol 2004 287 (3) : L510 L514.
10. Delpire E, Mount DB. Human and murine phenotypes associated with defects in cation-chloride cotransport. Annu Rev Physiol 2004 64 (4) : 803 843.
11. Malek SA, Coderre E, Stys PK. Aberrant chloride transport contributes to anoxic/ischemic white matter injury. J Neurosci 2003 23 (9) : 3826 3836.
12. McClellan JM, Goldstein RE, Erb HN, et al. Effects of administration of fluids and diuretics on glomerular filtration rate, renal blood flow, and urine output in healthy awake cats. Am J Vet Res 2006 67 (4) : 715 722.
13. Sjöström PA, Kron BG, Odlind BG. Determinants of furosemide delivery to its site of action. Clin Nephrol 1995 43 (Suppl. 1) : S38 S41.
14. Vree TB, van der Ven AJ. Clinical consequences of the biphasic elimination kinetics for the diuretic effect of furosemide and its acyl glucuronide in humans. J Pharm Pharmacol 1999 51 (3) : 239 248.
15. Wilcox CS. New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol 2002 13 (3) : 798 805.
16. Mizuma T, Benet LZ, Lin ET. Interactions of human serum albumin with furosemide glucuronide: a role of albumin in isomerization, hydrolysis, reversible binding and irreversible binding of a 1-O-acyl glucuronide metabolite. Biopharm Drug Dispos 1999 20 (3) : 131 136.
17. Trepanier LA. Potential interactions between non-steroidal anti-inflammatory drugs and other drugs. J Vet Emerg Crit Care 2005 15 (4) : 248 253.
18. Hasannejad H, Takeda M, Taki K, et al. Interactions of human organic anion transporters with diuretics. J Pharmacol Exp Ther 2004 308 (3) : 1021 1029.
19. Alebouyeh M, Takeda M, Onozato ML, et al. Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. J Pharmacol Sci 2003 93 (4) : 430 436.
20. Odlind B. Relationship between tubular secretion of furosemide and its saliuretic effect. J Pharmacol Exp Ther 1979 208 (3) : 515 521.
21. Lee MG, Chiou WL. Mechanism of ascorbic acid enhancement of the bioavailability and diuretic effect of furosemide. Drug Metab Dispos 1998 26 (5) : 401 407.
22. Friedman PA, Roch-Ramel F. Hemodynamic and natriuretic effects of bumetanide and furosemide in the cat. J Pharmacol Exp Ther 1977 203 (1) : 82 91.
23. Cataliotti A, Boerrigter G, Costello-Boerrigter LC, et al. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure. Circulation 2004 109 (13) : 1680 1685.
24. Singh A, Blackwell J, Neher J. Clinical inquiries. Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction? J Fam Pract 2005 54 (4) : 370 372.
25. Ravnan SL, Deedwania PC. The rational use of diuretics in heart failure. Curr Cardiol Rep 2003 5 (3) : 237 242.
26. Na KY, Oh YK, Han JS, et al. Upregulation of Na+ transporter abundances in response to chronic thiazide or loop diuretic treatment in rats. Am J Physiol Renal Physiol 2003 284 (1) : F133 F143.
27. Buffin-Meyer B, Younes-Ibrahim M, El Mernissi G, et al. Differential regulation of collecting duct Na+, K+-ATPase and K+ excretion by furosemide and piretanide: role of bradykinin. J Am Soc Nephrol 2004 15 (4) : 876 884.
28. Maril N, Margalit R, Mispelter J, et al. Sodium magnetic resonance imaging of diuresis: spatial and kinetic response. Magn Reson Med 2005 53 (3) : 545 552.
29. Sward K, Valsson F, Sellgren J, et al. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med 2005 31 (1) : 79 85.
30. Liss P, Nygren A, Ulfendahl HR, et al. Effect of furosemide or mannitol before injection of a non-ionic contrast medium on intrarenal oxygen tension. Adv Exp Med Biol 1999 471 : 353 359.
31. Lahet JJ, Lenfant F, Courderot-Masuyer C, et al. In vivo and in vitro antioxidant properties of furosemide. Life Sci 2003 73 (8) : 1075 1082.
32. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005 365 (9457) : 417 430.
33. Uchino S, Doig GS, Bellomo R, et al. Diuretics and mortality in acute renal failure. Crit Care Med 2004 32 (8) : 1669 1677.
34. Aravindan N, Shaw A. Effect of furosemide infusion on renal hemodynamics and angiogenesis gene expression in acute renal ischemia/reperfusion. Ren Fail 2006 28 (1) : 25 35.
35. Gammage M. Treatment of acute pulmonary oedema: diuresis or vasodilation? Lancet 1998 351 (9100) : 382 383.
36. Stanke F, Devillier P, Breant D, et al. Frusemide inhibits angiotensin II-induced contraction on human vascular smooth muscle. Br J Clin Pharmacol 1998 46 (6) : 571 575.
37. Jhund PS, Davie AP, McMurray JJ. Aspirin inhibits the acute venodilator response to furosemide in patients with chronic heart failure. J Am Coll Cardiol 2001 37 (5) : 1234 1238.
38. Greenberg S, McGowan C, Xie J, et al. Selective pulmonary and venous smooth muscle relaxation by furosemide: a comparison with morphine. J Pharmacol Exp Ther 1994 270 (3) : 1077 1085.
39. Carriere S, Desrosiers M, Friborg J, et al. The effect of furosemide on the intrarenal blood flow distribution in the dog. Can J Physiol Pharmacol 1972 50 (8) : 774 783.
40. Data JL, Rane A, Gerkens J, et al. The influence of indomethacin on the pharmacokinetics, diuretic response, and hemodynamics of furosemide in the dog. J Pharmacol Exp Ther 1978 206 (2) : 431 438.
41. Wronski T, Seeliger E, Persson PB, et al. The step response: a method to characterize mechanisms of renal blood flow autoregulation. Am J Physiol Renal Physiol 2003 285 (4) : F758 F764.
42. Biddle TL, Yu PN. Effect of furosemide on hemodynamics and lung water in acute pulmonary edema secondary to myocardial infarction. Am J Cardiol 1979 43 (1) : 86 90.
43. Pickkers P, Dormans TP, Russel FG, et al. Direct vascular effects of furosemide in humans. Circulation 1997 96 (6) : 1847 1852.
44. Javaheri S, Corbett W, Adams JM, et al. Acute respiratory acidosis: large-dose furosemide and cerebrospinal fluid ions. J Appl Physiol 1994 76 (6) : 2651 2655.
45. Reising CA, Chendrasekhar A, Wall PL, et al. Continuous dose furosemide as a therapeutic approach to acute respiratory distress syndrome (ARDS). J Surg Res 1999 82 (1) : 56 60.
46. Johnston GD, Hiatt WR, Nies AS, et al. Factors modifying the early nondiuretic vascular effects of furosemide in man. The possible role of renal prostaglandins. Circ Res 1983 53 (5) : 630 635.
47. Wiemer G, Fink E, Linz W, et al. Furosemide enhances the release of endothelial kinins, nitric oxide and prostacyclin. J Pharmacol Exp Ther 1994 271 (3) : 1611 1615.
48. Wallach S, Charbon GA, Beijer HJ, et al. Furosemide vasodilates the canine gastrointestinal tract. J Clin Pharmacol 1982 22 (8-9) : 348 358.
49. Wallach S, Charbon GA, Beijer HJ, et al. Effect of furosemide on biliary secretion, pancreatic blood flow, and pancreatic exocrine secretion. J Clin Pharmacol 1983 23 (10) : 401 413.
50. Pickkers P, Russel FG, Thien T, et al. Only weak vasorelaxant properties of loop diuretics in isolated resistance arteries from man, rat and guinea pig. Eur J Pharmacol 2003 466 (3) : 281 287.
51. Stevens EL, Uyehara CF, Southgate WM, et al. Furosemide differentially relaxes airway and vascular smooth muscle in fetal, newborn, and adult guinea pigs. Am Rev Respir Dis 1992 146 (5 Part 1) : 1192 1197.
52. Johnston GD, Nicholls DP, Leahey WJ. The dose-response characteristics of the acute non-diuretic peripheral vascular effects of frusemide in normal subject. Br J Clin Pharmacol 1984 18 (1) : 75 81.
53. Stanke-Labesque F, Cracowski JL, Bedouch P, et al. Furosemide inhibits thromboxane A2-induced contraction in isolated human internal mammary artery and saphenous vein. J Cardiovasc Pharmacol 2000 35 (4) : 531 537.
54. 2+ influx pathways associated with oxytocin-induced contractions of rat myometrium. Gen Physiol Biophys 1995 14 (5) : 427 426.
55. Datar S, McCauley FA, Wilson TW. Testing the "redirection hypothesis" of prostaglandin metabolism in the kidney. Prostaglandins 1987 33 (2) : 275 285.
56. Pourageaud F, Bappel-Gozalbes C, Marthan R, et al. Role of EDHF in the vasodilatory effect of loop diuretics in guinea-pig mesenteric resistance arteries. Br J Pharmacol 2000 131 (6) : 1211 1219.
57. Corboz MR, Ballard ST, Inglis SK, et al. Dilatory effect of furosemide on rat tracheal arterioles and venules. Am J Respir Crit Care Med 1997 156 (2 Part 1) : 478 483.
58. Fazio M, Bardelli M, Cominotto F, et al. Haemoconcentration, shear-stress increase and carotid artery diameter regulation after furosemide administration in older hypertensives. Exp Gerontol 2001 36 (3) : 571 581.
59. Francis GS, Siegel RM, Goldsmith SR, et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Ann Intern Med 1985 103 (1) : 1 6.
60. Martin GS, Moss M, Wheeler AP, et al. A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005 33 (8) : 1681 1687.
61. Abrahams Z, Pang MY, Lam EK, et al. What is the plasma cofactor required by diuretics for direct vascular relaxant effect in vitro? J Hypertens 1998 16 (6) : 801 809.
62. Andreasen F, Christensen JH. The effect of furosemide on vascular smooth muscle is influenced by plasma protein. Pharmacol Toxicol 1988 65 (3) : 324 326.
63. Holland SD, Williamson HE. Acute effects of high ceiling diuretics on pancreatic blood flow and function. J Pharmacol Exp Ther 1984 229 (2) : 440 446.
64. Ong KC, Kor AC, Chong WF, et al. Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004 169 (9) : 1028 1033.
65. Nishino T, Ide T, Sudo T, et al. Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea. Am J Respir Crit Care Med 2000 161 (6) : 1963 1967.
66. Novembre E, Frongia G, Lombardi E, et al. The preventative effect and duration of action of two doses of inhaled furosemide on exercise-induced asthma in children. J Allergy Clin Immunol 1995 96 (6 Part 1) : 906 909.
67. Polosa R, Rajakulasingam K, Prosperini G, et al. Relative potencies and time course of changes in adenosine 5′-monophosphate airway responsiveness with inhaled furosemide and bumetanide in asthma. J Allergy Clin Immunol 1993 92 (2) : 288 297.
68. Nehashi S, Nishino T, Ide T. Inhaled furosemide inhibits behavioral response to airway occlusion in anesthetized cats. Anesthesiology 2001 95 (5) : 1234 1237.
69. Sudo T, Hayashi F, Nishino T. Responses of tracheobronchial receptors to inhaled furosemide in anesthetized rats. Am J Respir Crit Care Med 2000 162 (3 Part 1) : 971 975.
70. Prat J, Mullol J, Ramis I, et al. Release of chemical mediators and inflammatory cell influx during early allergic reaction in the nose: effect of furosemide. J Allergy Clin Immunol 1993 92 (2) : 248 254.
71. Nucera E, Schiavino D, Milani A, et al. Effect of pre-treatment with inhaled furosemide on allergen nasal challenge. Am J Rhinol 1998 12 (5) : 359 361.
72. Willis EF, Clough GF, Church MK. Investigation into the mechanisms by which nedocromil sodium, frusemide, and bumetanide inhibit the histamine-induced itch and flare response in human skin in vivo. Clin Exp Allergy 2004 34 (3) : 450 455.
73. Granados-Soto V, Arguelles CF, Alvarez-Leefmans FJ. Peripheral and central antinociceptive actions of Na+-K+-2Cl- cotransporter blockers on formalin-induced nociception in rats. Pain 2005 114 (1-2) : 231 238.
74. Moosavi SH, Binks AP, Lansing RW, et al. Effect of inhaled furosemide on air hunger induced in healthy humans. Respir Physiol Neurobiol 2007 156 (1) : 1 8.
75. Yen ZS, Chen SC. Best evidence topic report. Nebulised furosemide in acute adult asthma. Emerg Med J 2005 22 (9) : 654 655.
76. Polosa R, Rajakulasingam K, Prosperini G, et al. Inhaled loop diuretics and basal airway responsiveness in man: evidence of a role for cyclo-oxygenase products. Eur Respir J 1995 8 (4) : 593 599.
77. Foresi A, Pelucchi A, Mastropasqua B, et al. Effect of inhaled furosemide and torasemide on bronchial response to ultrasonically nebulized distilled water in asthmatic subjects. Am Rev Respir Dis 1992 146 (2) : 364 368.
78. Padrid P. Chronic lower airway disease in the dog and cat. Probl Vet Med 1992 4 (2) : 320 344.
79. Widdicombe JH, Nathanson IT, Highland E. Effect of "loop" diuretics on ion transport by dog tracheal epithelium. Am J Physiol 1983 245 (5 Part 1) : C388 C396.
80. Hesdorffer DC, Stables JP, Hauser WA, et al. Are certain diuretics also anticonvulsants? Ann Neurol 2001 50 (4) : 458 462.
81. Gutschmidt KU, Stenkamp K, Buchheim K, et al. Anticonvulsant actions of furosemide in vitro. Neuroscience 1999 91 (4) : 1471 1481.
82. Schwartzkroin PA, Baraban SC, Hochman DW. Osmolarity, ionic flux, and changes in brain excitability. Epilepsy Res 1998 32 (1-2) : 275 285.
83. Haglund MM, Hochman DW. Furosemide and mannitol suppression of epileptic activity in the human brain. J Neurophysiol 2005 94 (2) : 907 918.
84. Holtkamp M, Matzen J, Buchheim K, et al. Furosemide terminates limbic status epilepticus in freely moving rats. Epilepsia 2003 44 (9) : 1141 1144.
85. Hochman DW, Baraban SC, Owens JW, et al. Dissociation of synchronization and excitability in furosemide blockade of epileptiform activity. Science 1995 270 (5233) : 99 102.
86. Stringer JL, Pan E. Effect of seizures and diuretics on the osmolality of the cerebrospinal fluid. Brain Res 1997 745 (1-2) : 328 330.
87. Jarolimek W, Lewen A, Misgeld U. A furosemide-sensitive K+-Cl- cotransporter counteracts intracellular Cl- accumulation and depletion in cultured rat midbrain neurons. J Neurosci 1999 19 (12) : 4695 4704.
88. Read SJ, Smith MI, Benham CD, et al. Furosemide inhibits regenerative cortical spreading depression in anesthetized cats. Cephalalgia 1997 17 (8) : 826 832.
89. Barbaro NM, Takahashi DK, Baraban SC. A potential role for astrocytes in mediating the antiepileptic actions of furosemide in vitro. Neuroscience 2004 128 (3) : 655 663.
90. Walz W, Hertz L. Intense furosemide-sensitive potassium accumulation in astrocytes in the presence of pathologically high extracellular potassium levels. J Cereb Blood Flow Metab 1984 4 (2) : 301 304.
91. Walz W, Kimelberg HK. Differences in cation transport properties of primary astrocyte cultures from mouse and rat brain. Brain Res 1985 340 (2) : 333 340.
92. Pollay M, Fullenwider C, Roberts PA, et al. Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg 1983 59 (6) : 945 950.
93. Barbosa AP, Cabral SA. New therapies for intracranial hypertension. J Pediatr (Rio J) 2003 79 (Suppl. 2) : S139 S148.
94. Melby JM, Miner LC, Reed DJ. Effect of acetazolamide and furosemide on the production and composition of cerebrospinal fluid from the cat choroid plexus. Can J Physiol Pharmacol 1982 60 (3) : 405 409.
95. Johnson DC, Frankel HM, Kazemi H. Effect of furosemide on cerebrospinal fluid composition. Respir Physiol 1984 56 (3) : 301 308.
96. Seo M, Choi H, Lee K, et al. Transcranial Doppler ultrasound analysis of resistive index in rostral and cerebral arteries in dogs. J Vet Sci 2005 6 (1) : 61 66.
97. Kang MY, Tsuchiya M, Packer L, et al. In vitro study on antioxidant potential of various drugs used in the perioperative period. Acta Anaesthesiol Scand 1998 42 (1) : 4 12.
98. Reyes AJ. The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure. Eur J Heart Fail 2005 7 (4) : 461 467.
99. Kapucu LO, Azizoglu F, Ayvaz G, et al. Effects of diuretics on iodine uptake in non-toxic goiter: comparison with low-iodine diet. Eur J Nucl Mol Imaging 2003 30 (9) : 1270 1272.
100. Seabold JE, Ben-Haim S, Pettit WA, et al. Diuretic-enhanced I-131 clearance after ablation therapy for differentiated thyroid cancer. Radiology 1993 187 (3) : 839 842.
101. Hamburger JI. Diuretic augmentation of 131-I uptake in inoperable thyroid cancer. N Engl J Med 1969 280 (20) : 1091 1094.
102. Rillema JA, Hill MA. Prolactin regulation of the pendrin-iodide transporter in the mammary gland. Am J Physiol Endocrinol Metab 2003 284 (1) : E25 E28.
103. Szwed JJ, Kleit SA, Hamburger RJ. Effect of furosemide and chlorothiazide on the thoracic duct lymph flow in the dog. J Lab Clin Med 1972 79 (5) : 693 700.
104. la Cour M, Baekgaard A, Zeuthen T. Antibodies against a furosemide binding protein from ehrlich ascites tumour cells inhibit Na+, K+, Cl- co-transport in frog retinal pigment epithelium. Acta Ophthalmol Scand 1997 75 (4) : 405 408.
105. Geck P, Heinz E, Pfeiffer B. Influence of high ceiling diuretics on ion fluxes and cell volume of ehrlich ascites tumour cells. Scand Audiol Suppl 1981 14 (Suppl.) : 25 37.
106. Razis DV, Athanasiou A, Dadiotis L. Diuretics in malignant effusions and edemas of generalized cancer. J Med 1976 7 (6) : 449 461.
107. Plumb DC. Veterinary Drug Handbook. Furosemide, 4th edn. Minnesota : Blackwell Publishing 2002, pp. 394 397.
108. Weber KT. Furosemide in the long-term management of heart failure: the good, the bad, and the uncertain. J Am Coll Cardiol 2004 44 (6) : 1308 1310.
109. Lee CT, Chen HC, Lai LW, et al. Effects of furosemide on renal calcium handling. Am J Physiol Renal Physiol 2007 293 (4) : F1231 F1237.
110. Bushinsky DA, Favus MJ, Langman CB, et al. Mechanism of chronic hypercalciuria with furosemide: increased calcium absorption. Am J Physiol 1986 251 (1 Pt 2) : F17 F24.
111. Law PH, Sun Y, Bhattacharya SK, et al. Diuretics and bone loss in rats with aldoseronism. J Am Coll Cardiol 2005 46 (1) : 142 146.
112. Bartoli E, Arras S, Faedda R, et al. Blunting of furosemide diuresis by aspirin in man. J Clin Pharmacol 1980 20 (7) : 452 458.
113. Berg KJ, Loew D. Inhibition of furosemide-induced natriuresis by acetylsalicylic acid in dogs. Scand J Clin Lab Invest 1977 37 (2) : 125 131.
114. Müller FO, Middle MV, Schall R, et al. An evaluation of the interaction of meloxicam with frusemide in patients with compensated chronic cardiac failure. Br J Clin Pharmacol 1997 44 (4) : 393 398.
115. Kidd LB, Salavaggione OE, Szumlanski CL, et al. Thiopurine methyltransferase activity in red blood cells of dogs. J Vet Intern Med 2004 18 (2) : 214 218.
116. Kondo CS, Macchionne M, Nakagawa NK, et al. Effects of intravenous furosemide on mucociliary transport and rheologic properties of patients under mechanical ventilation. Crit Care 2002 6 (1) : 81 87.
117. Cook DJ, Tudball CF. Potentators and bolus intravenous furosemide. Lancet 2001 358 (9290) : 1373 1374.
118. Scarpelli DG. Toxicology of the pancreas. Toxicol Appl Pharmacol 1989 101 (3) : 543 554.
119. Hermansen K, Schmitz O, Arnfred J, et al. Effects of furosemide and indapamide upon pancreatic insulin and somatostatin secretion in vitro. Diabetes Res 1986 3 (4) : 221 223.
120. 2+ fluxes in beta-cells. Am J Physiol 1988 255 (5 Part 1) : E591 E596.
121. Reid B, Song B, McCaig CD, et al. Wound healing in rat cornea: the role of electric currents. FASEB J 2005 19 (3) : 379 386.
122. Patarca R, Candia OA, Reinach PS. Mode of inhibition of active chloride transport in the frog cornea by furosemide. Am J Physiol 1983 245 (6) : F660 F669.
123. Shankaran S, Poland RL. The displacement of bilirubin from albumin by furosemide. J Pediatr 1997 90 (4) : 642 646.
124. Earl G, Davenport J, Narula J. Furosemide challenge in patients with heart failure and adverse reactions to sulfa-containing diuretics. Ann Intern Med 2003 138 (4) : 358 359.
125. Trepanier LA. Idiosyncratic toxicity associated with potentiated sulfonamides in the dog. J Vet Pharmacol Ther 2004 27 (3) : 129 138.
126. Ochoa PG, Arribas MT, Mena JM, et al. Cutaneous adverse reaction to furosemide treatment: new clinical finding. Can Vet J 2006 47 (6) : 576 578.
127. Sommers SC, Higgins TE, Kimelblatt BJ. Chronic aortitis following furosemide therapy. Arch Pathol Lab Med 1984 108 (4) : 293 294.
128. Lim CF, Loidl NM, Kennedy JA, et al. Drug effects on triiodothyronine uptake by rat anterior pituitary cells in vitro. Exp Clin Endocrinol Diabetes 1996 104 (2) : 151 157.
129. Gulikers KP, Panciera DL. Influence of various medications on canine thyroid function. Comp Contin Edu Pract Vet 2002 24 (7) : 511 523.
130. Stockigt JR, Lim CF, Barlow JW, et al. Interaction of furosemide with serum thyroxine-binding sites: in vivo and in vitro studies and comparison with other inhibitors. J Clin Endocrinol Metab 1985 60 (5) : 1025 1031.
131. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med 1995 333 (25) : 1688 1694.
132. Daminet S, Ferguson DC. Influence of drugs on thyroid function in dogs. J Vet Intern Med 2003 17 (4) : 463 472.